These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 34642415)

  • 1. Antibodies against phosphorylcholine in hospitalized versus non-hospitalized obese subjects.
    Jujić A; Korduner J; Holm H; Engström G; Bachus E; Bhattacharya P; Nilsson PM; Frostegård J; Magnusson M
    Sci Rep; 2021 Oct; 11(1):20246. PubMed ID: 34642415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low levels of IgM antibodies against phosphorylcholine predict development of acute myocardial infarction in a population-based cohort from northern Sweden.
    Grönlund H; Hallmans G; Jansson JH; Boman K; Wikström M; de Faire U; Frostegård J
    Eur J Cardiovasc Prev Rehabil; 2009 Jun; 16(3):382-6. PubMed ID: 19369878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rheumatoid cachexia is associated with dyslipidemia and low levels of atheroprotective natural antibodies against phosphorylcholine but not with dietary fat in patients with rheumatoid arthritis: a cross-sectional study.
    Elkan AC; Håkansson N; Frostegård J; Cederholm T; Hafström I
    Arthritis Res Ther; 2009; 11(2):R37. PubMed ID: 19284557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low levels of IgM antibodies to phosphorylcholine predict cardiovascular disease in 60-year old men: effects on uptake of oxidized LDL in macrophages as a potential mechanism.
    de Faire U; Su J; Hua X; Frostegård A; Halldin M; Hellenius ML; Wikström M; Dahlbom I; Grönlund H; Frostegård J
    J Autoimmun; 2010 Mar; 34(2):73-9. PubMed ID: 19726160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between dietary and metabolic factors and IgM antibodies to phosphorylcholine and malondialdehyde in patients with systemic lupus erythematosus and population-based matched controls.
    Lourdudoss C; Ajeganova S; Frostegård J
    Clin Exp Rheumatol; 2018; 36(3):428-433. PubMed ID: 29745894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low levels of IgM antibodies against phosphorylcholine-A increase mortality risk in patients undergoing haemodialysis.
    Carrero JJ; Hua X; Stenvinkel P; Qureshi AR; Heimbürger O; Bárány P; Lindholm B; Frostegård J
    Nephrol Dial Transplant; 2009 Nov; 24(11):3454-60. PubMed ID: 19549697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgM anti-phosphorylcholine antibodies associate with senescent and IL-17+ T cells in SLE patients with a pro-inflammatory lipid profile.
    López P; Rodríguez-Carrio J; Martínez-Zapico A; Pérez-Álvarez ÁI; Benavente L; Caminal-Montero L; Suárez A
    Rheumatology (Oxford); 2020 Feb; 59(2):407-417. PubMed ID: 31302689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low levels of natural IgM antibodies against phosphorylcholine are independently associated with vascular remodeling in patients with coronary artery disease.
    Gleissner CA; Erbel C; Haeussler J; Akhavanpoor M; Domschke G; Linden F; Doesch AO; Conradson G; Buss SJ; Hofmann NP; Gitsioudis G; Katus HA; Korosoglou G
    Clin Res Cardiol; 2015 Jan; 104(1):13-22. PubMed ID: 25103819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different subclasses and isotypes of antibodies against phosphorylcholine in haemodialysis patients: association with mortality.
    Samal SK; Qureshi AR; Rahman M; Stenvinkel P; Frostegård J
    Clin Exp Immunol; 2020 Jul; 201(1):94-104. PubMed ID: 32297318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term prognostic value of IgM antibodies against phosphorylcholine for adverse cardiovascular events in patients with stable coronary heart disease.
    Imhof A; Koenig W; Jaensch A; Mons U; Brenner H; Rothenbacher D
    Atherosclerosis; 2015 Dec; 243(2):414-20. PubMed ID: 26520895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased prevalence of vulnerable atherosclerotic plaques and low levels of natural IgM antibodies against phosphorylcholine in patients with systemic lupus erythematosus.
    Anania C; Gustafsson T; Hua X; Su J; Vikström M; de Faire U; Heimbürger M; Jogestrand T; Frostegård J
    Arthritis Res Ther; 2010; 12(6):R214. PubMed ID: 21092251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low levels of antibodies against phosphorylcholine predict development of stroke in a population-based study from northern Sweden.
    Fiskesund R; Stegmayr B; Hallmans G; Vikström M; Weinehall L; de Faire U; Frostegård J
    Stroke; 2010 Apr; 41(4):607-12. PubMed ID: 20150554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies against Phosphorylcholine and Malondialdehyde during the First Two Years of Life.
    Thiagarajan D; Lundström SL; Pershagen G; Almqvist C; Andolf E; Hedman A; Berg O; Oparina N; Frostegård J
    J Immunol; 2020 Oct; 205(8):2109-2116. PubMed ID: 32887753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients with polycystic ovary syndrome have lower levels of IgM anti-phosphorylcholine antibodies than healthy women.
    Gingnell M; Dahlbom I; Lindholm A; Hudecova M; Arnadottir R; Hansson T; Sundstrom-Poromaa I
    Gynecol Endocrinol; 2011 Jul; 27(7):486-90. PubMed ID: 20645890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgM antibodies against phosphorylcholine measured early after acute ST-elevation myocardial infarction in relation to atherosclerotic disease burden and long-term clinical outcome.
    Knudsen EC; Seljeflot I; Aksnes TA; Eritsland J; Arnesen H; Andersen GØ
    PLoS One; 2019; 14(4):e0215640. PubMed ID: 31002684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies of IgM subclass to phosphorylcholine and oxidized LDL are protective factors for atherosclerosis in patients with hypertension.
    Su J; Georgiades A; Wu R; Thulin T; de Faire U; Frostegård J
    Atherosclerosis; 2006 Sep; 188(1):160-6. PubMed ID: 16307748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A genome-wide association study of IgM antibody against phosphorylcholine: shared genetics and phenotypic relationship to chronic lymphocytic leukemia.
    Chen X; Gustafsson S; Whitington T; Borné Y; Lorentzen E; Sun J; Almgren P; Su J; Karlsson R; Song J; Lu Y; Zhan Y; Hägg S; Svensson P; Smedby KE; Slager SL; Ingelsson E; Lindgren CM; Morris AP; Melander O; Karlsson T; de Faire U; Caidahl K; Engström G; Lind L; Karlsson MCI; Pedersen NL; Frostegård J; Magnusson PKE
    Hum Mol Genet; 2018 May; 27(10):1809-1818. PubMed ID: 29547969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of IgG1 isotype phosphorylcholine antibodies for the treatment of inflammatory cardiovascular diseases.
    de Vries MR; Ewing MM; de Jong RCM; MacArthur MR; Karper JC; Peters EAB; Nordzell M; Karabina SAP; Sexton D; Dahlbom I; Bergman A; Mitchell JR; Frostegård J; Kuiper J; Ninio E; Jukema JW; Pettersson K; Quax PHA
    J Intern Med; 2021 Jul; 290(1):141-156. PubMed ID: 33342002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies against phosphorylcholine and protection against atherosclerosis, cardiovascular disease and chronic inflammation.
    Frostegård J
    Expert Rev Clin Immunol; 2022 May; 18(5):525-532. PubMed ID: 35471137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galectin-4 levels in hospitalized versus non-hospitalized subjects with obesity: the Malmö Preventive Project.
    Korduner J; Holm H; Jujic A; Melander O; Pareek M; Molvin J; Råstam L; Lindblad U; Daka B; Leosdottir M; Nilsson PM; Bachus E; Olsen MH; Magnusson M
    Cardiovasc Diabetol; 2022 Jul; 21(1):125. PubMed ID: 35780152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.